{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:09:25Z","timestamp":1791947365574,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.3129\/i09-003","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T13:14:37Z","timestamp":1254230077000},"page":"193-197","source":"Crossref","is-referenced-by-count":9,"title":["Effects of some ophthalmic medications on pupil size: a literature review"],"prefix":"10.1016","volume":"44","author":[{"given":"Elena S.","family":"Novitskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C.B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Nagendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3129\/i09-003_bib1","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1185\/030079904X5959","article-title":"A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability","volume":"20","author":"Donnenfeld","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.3129\/i09-003_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)76047-7","article-title":"Mydriasis and conjunctival paresthesia from local gentamicin","volume":"99","author":"Awan","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-003_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10384-004-0149-9","article-title":"Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy","volume":"49","author":"Yuen","year":"2005","journal-title":"Jpn J Ophthalmol"},{"key":"10.3129\/i09-003_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jcrs.2003.12.037","article-title":"Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes","volume":"30","author":"Thordsen","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.3129\/i09-003_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/108076803762718097","article-title":"A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension","volume":"19","author":"Mundorf","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.3129\/i09-003_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0886-3350(01)00769-6","article-title":"Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions","volume":"27","author":"McDonald","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"10.3129\/i09-003_bib7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0161-6420(98)91048-X","article-title":"Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2","volume":"105","author":"LeBlanc","year":"1998","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-003_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00061198-200204000-00007","article-title":"Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension","volume":"11","author":"Katz","year":"2002","journal-title":"J Glaucoma"},{"key":"10.3129\/i09-003_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0161-6420(97)30349-2","article-title":"Brimonidine tartrate: a one-month dose response study","volume":"104","author":"Derick","year":"1997","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-003_bib10","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jcrs.2004.12.064","article-title":"Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels","volume":"31","author":"Marx-Gross","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"10.3129\/i09-003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(71)91088-9","article-title":"Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture","volume":"1","author":"Becker","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-003_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0014-4835(83)90103-3","article-title":"Effect of thymoxamine on the human pupil","volume":"36","author":"Lee","year":"1983","journal-title":"Exp Eye Res"},{"key":"10.3129\/i09-003_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archopht.1978.03910050533006","article-title":"Thymoxamine test. Differentiating angle-closure glaucoma form open-angle glaucoma with narrow angles","volume":"96","author":"Wand","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib14","first-page":"400","article-title":"Thymoxamine hydrochloride: effects on the facility of outflow and intraocular pressure","volume":"15","author":"Wand","year":"1976","journal-title":"Invest Ophthalmol"},{"key":"10.3129\/i09-003_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archopht.1996.01100140146006","article-title":"A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group","volume":"114","author":"Stewart","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archopht.1988.01060140058024","article-title":"Short-term effects of unilateral 1% apraclonidine therapy","volume":"106","author":"Robin","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archopht.1988.01060140225029","article-title":"Apracloni-dine. A one-week dose-response study","volume":"106","author":"Jampel","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00917987","article-title":"Apraclonidine and cloni-dine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers","volume":"16","author":"Y\u00fcksel","year":"1992","journal-title":"Int Ophthalmol"},{"key":"10.3129\/i09-003_bib19","first-page":"763","article-title":"The effect of Timolol Maleate on tonic accommodation, tonic vergence, and pupil diameter","volume":"25","author":"Gilmartin","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3129\/i09-003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(01)01337-X","article-title":"A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension6 month data","volume":"133","author":"Nordmann","year":"2002","journal-title":"Am J Ophthal-mol"},{"key":"10.3129\/i09-003_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1755-3768.1988.tb04008.x","article-title":"A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension","volume":"66","author":"Feghali","year":"1988","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.3129\/i09-003_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-4835(71)80095-7","article-title":"The adrenergic receptors of the intraocular muscles in man. An in vitro study","volume":"11","author":"Kern","year":"1971","journal-title":"Exp Eye Res"},{"key":"10.3129\/i09-003_bib23","first-page":"502","article-title":"The adrenergic receptors of the intraocular muscles of the human eye","volume":"15","author":"van Alphen","year":"1976","journal-title":"Invest Ophthalmol"},{"key":"10.3129\/i09-003_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1463-5224.2006.00469.x","article-title":"Comparison of the effects of topical administration of a fixed combination of dor-zolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs","volume":"9","author":"Plummer","year":"2006","journal-title":"Vet Ophthalmol"},{"key":"10.3129\/i09-003_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archopht.1986.01050130056019","article-title":"Betaxolol vs tim-olol. A six-month double-blind comparison","volume":"104","author":"Stewart","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/108076802317373860","article-title":"A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma","volume":"18","author":"Halper","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.3129\/i09-003_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/bjo.87.6.792","article-title":"The effect of topical glaucoma medications evaluated by perimetry","volume":"87","author":"Lin","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-003_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00170540","article-title":"Comparative tolerability of topical carbonic anhyd-rase inhibitor MK-927 and its S-enantiomer MK-417","volume":"229","author":"Pfeiffer","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.3129\/i09-003_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1463-5224.2003.00308.x","article-title":"Effects of topical administration of 1% brinzolamide on normal cat eyes","volume":"6","author":"Gray","year":"2003","journal-title":"Vet Ophthalmol"},{"key":"10.3129\/i09-003_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bjo.85.8.983","article-title":"Meta-analysis of randomised controlled trials comparing latanoprost with tim-olol in the treatment of patients with open angle glaucoma or ocular hypertension","volume":"85","author":"Zhang","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-003_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02849907","article-title":"Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol","volume":"24","author":"Dunker","year":"2007","journal-title":"Adv Ther"},{"key":"10.3129\/i09-003_bib32","first-page":"13","article-title":"Clinical evaluation of isopropyl unoprostone (Rescula), in the adjunctive treatment of primary open angle glaucoma [in Polish]","volume":"103","author":"Zarnowski","year":"2001","journal-title":"Klin Oczna"},{"key":"10.3129\/i09-003_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00061198-200308000-00002","article-title":"Effects of 0.005% latanoprost on ocular anterior structures and ciliary body thickness","volume":"12","author":"Marchini","year":"2003","journal-title":"J Glaucoma"},{"key":"10.3129\/i09-003_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archopht.1964.00970010652008","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. III. Changes in visual function and pupil size during topical dexamethasone application","volume":"71","author":"Armaly","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-003_bib35","first-page":"424","article-title":"\u201cSteroid-induced\u201d mydriasis and ptosis","volume":"10","author":"Newsome","year":"1971","journal-title":"Invest Ophthalmol"},{"key":"10.3129\/i09-003_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.1978.03290040025013","article-title":"Toxic effects of local anesthetics","volume":"240","author":"Burns","year":"1978","journal-title":"JAMA"},{"key":"10.3129\/i09-003_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00006324-197705000-00002","article-title":"Effects of topical anesthetics on phenylephrine-induced mydriasis","volume":"54","author":"Lyle","year":"1977","journal-title":"Am J Optom Physiol Opt"},{"key":"10.3129\/i09-003_bib38","first-page":"1581","article-title":"Evaluation of potentiating effect of a drop of lig-nocaine on tropicamide-induced mydriasis","volume":"42","author":"Ghose","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3129\/i09-003_bib39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jcrs.2007.05.020","article-title":"Pupil dilation with intracameral lido-caine during phacoemulsification","volume":"33","author":"Jayadev","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.3129\/i09-003_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0301-4738.37598","article-title":"Pupil dilation with intracameral lidocaine during phacoemulsification: benefits for the patient and surgeon","volume":"56","author":"Nikeghbali","year":"2008","journal-title":"Indian J Ophthalmol"},{"key":"10.3129\/i09-003_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jcrs.2007.09.036","article-title":"Separate and additive mydriatic effects of lidocaine hydrochloride, phenylephrine, and cyclo-pentolate after intracameral injection","volume":"34","author":"Lundberg","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.3129\/i09-003_bib42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF01949747","article-title":"Morphine eye-drops reduce homatropine induced mydriasis in man","volume":"40","author":"Fanciullacci","year":"1984","journal-title":"Experientia"},{"key":"10.3129\/i09-003_bib43","first-page":"347","article-title":"Safety and toleration of oxymetazoline ophthalmic solution","volume":"2","author":"Samson","year":"1980","journal-title":"Phar-matherapeutica"},{"key":"10.3129\/i09-003_bib44","first-page":"5","article-title":"Prevention of peroperative miosis: comparison between prostaglandin inhibitors. Sodium diclofenac and indomethacin in local application [in French]","volume":"15","author":"Dimitrakos","year":"1992","journal-title":"J Fr Ophtalmol"},{"key":"10.3129\/i09-003_bib45","first-page":"36","article-title":"Clinical study of diclofenac sodium eye-drops used before and after cataract operation","volume":"15","author":"Zhang","year":"1999","journal-title":"Yan Ke Xue Bao"},{"key":"10.3129\/i09-003_bib46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/eye.2000.157","article-title":"The effect of pre-opera-tive topical flurbiprofen or diclofenac on pupil dilatation","volume":"14","author":"Thaller","year":"2000","journal-title":"Eye"},{"key":"10.3129\/i09-003_bib47","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0161-6420(82)34693-X","article-title":"Inhibitors of surgically induced miosis","volume":"89","author":"Duffin","year":"1982","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-003_bib48","first-page":"193","article-title":"The effects of diclofenac on cryo-induced miosis","volume":"20","author":"al-Salem","year":"1996","journal-title":"Int Ophthalmol"},{"key":"10.3129\/i09-003_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.77.10.639","article-title":"The fixed dilated pupil after cataract surgery-is it related to intraocular use of hypromellose?","volume":"77","author":"Tan","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-003_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bjo.79.6.541","article-title":"Pupil size and reactivity following hy-droxypropyl methylcellulose and sodium hyaluronate","volume":"79","author":"Eason","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-003_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2415-7-2","article-title":"Heavier molecular weight ocular viscoelastic devices and timing of postoperative review following cataract surgery","volume":"7","author":"Thirumalai","year":"2007","journal-title":"BMC Ophthalmol"},{"key":"10.3129\/i09-003_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0886-3350(00)00568-X","article-title":"Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery","volume":"27","author":"Holzer","year":"2001","journal-title":"J Cataract Re-fact Surg"},{"key":"10.3129\/i09-003_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bjo.85.2.139","article-title":"Intraocular pressure rise after small incision cataract surgery: a randomised intraindivid-ual comparison of two dispersive viscoelastic agents","volume":"85","author":"Rainer","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-003_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s004170000192","article-title":"Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes","volume":"238","author":"Schwenn","year":"2000","journal-title":"Grae-fes Arch Clin Exp Ophthalmol"},{"key":"10.3129\/i09-003_bib55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/02713688709034844","article-title":"Influence of sodium hyaluron-ate on the miotic effect of pilocarpine in rabbits","volume":"6","author":"Camber","year":"1987","journal-title":"Curr Eye Res"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209801580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418209801580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:56:12Z","timestamp":1542707772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418209801580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0008418209801580"],"URL":"https:\/\/doi.org\/10.3129\/i09-003","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}